<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with OASIS Tables with MathML3 v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-archive-oasis-article1-mathml3.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jpoasis-nisons2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Clin Case Rep</journal-id><journal-id journal-id-type="iso-abbrev">Clin Case Rep</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)2050-0904</journal-id><journal-id journal-id-type="publisher-id">CCR3</journal-id><journal-title-group><journal-title>Clinical Case Reports</journal-title></journal-title-group><issn pub-type="epub">2050-0904</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6982504</article-id><article-id pub-id-type="doi">10.1002/ccr3.2581</article-id><article-id pub-id-type="publisher-id">CCR32581</article-id><article-categories><subj-group subj-group-type="overline"><subject>Case Report</subject></subj-group><subj-group subj-group-type="heading"><subject>Case Reports</subject></subj-group></article-categories><title-group><article-title>An infant with refractory cytomegalovirus&#x02010;induced thrombocytopenia</article-title><alt-title alt-title-type="left-running-head">UEMURA et al.</alt-title></title-group><contrib-group><contrib id="ccr32581-cr-0001" contrib-type="author" corresp="yes"><name><surname>Uemura</surname><given-names>Suguru</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-7461-9138</contrib-id><xref ref-type="aff" rid="ccr32581-aff-0001">
<sup>1</sup>
</xref><address><email>sgr3u31@yahoo.co.jp</email></address></contrib><contrib id="ccr32581-cr-0002" contrib-type="author"><name><surname>Mori</surname><given-names>Takeshi</given-names></name><xref ref-type="aff" rid="ccr32581-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="ccr32581-cr-0003" contrib-type="author"><name><surname>Nino</surname><given-names>Nanako</given-names></name><xref ref-type="aff" rid="ccr32581-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="ccr32581-cr-0004" contrib-type="author"><name><surname>Sakakibara</surname><given-names>Nana</given-names></name><xref ref-type="aff" rid="ccr32581-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="ccr32581-cr-0005" contrib-type="author"><name><surname>Takafuji</surname><given-names>Satoru</given-names></name><xref ref-type="aff" rid="ccr32581-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="ccr32581-cr-0006" contrib-type="author"><name><surname>Myojin</surname><given-names>Shota</given-names></name><xref ref-type="aff" rid="ccr32581-aff-0002">
<sup>2</sup>
</xref></contrib><contrib id="ccr32581-cr-0007" contrib-type="author"><name><surname>Takami</surname><given-names>Yuichi</given-names></name><xref ref-type="aff" rid="ccr32581-aff-0002">
<sup>2</sup>
</xref></contrib><contrib id="ccr32581-cr-0008" contrib-type="author"><name><surname>Morioka</surname><given-names>Ichiro</given-names></name><xref ref-type="aff" rid="ccr32581-aff-0003">
<sup>3</sup>
</xref></contrib><contrib id="ccr32581-cr-0009" contrib-type="author"><name><surname>Nishimura</surname><given-names>Noriyuki</given-names></name><xref ref-type="aff" rid="ccr32581-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="ccr32581-cr-0010" contrib-type="author"><name><surname>Kugo</surname><given-names>Masaaki</given-names></name><xref ref-type="aff" rid="ccr32581-aff-0002">
<sup>2</sup>
</xref></contrib><contrib id="ccr32581-cr-0011" contrib-type="author"><name><surname>Iijima</surname><given-names>Kazumoto</given-names></name><xref ref-type="aff" rid="ccr32581-aff-0001">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="ccr32581-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Department of Pediatrics</named-content>
<institution>Kobe University Graduate School of Medicine</institution>
<city>Kobe</city>
<country country="JP">Japan</country>
</aff><aff id="ccr32581-aff-0002">
<label><sup>2</sup></label>
<named-content content-type="organisation-division">Department of Pediatrics</named-content>
<institution>Japanese Red Cross Society Himeji Hospital</institution>
<city>Himeji</city>
<country country="JP">Japan</country>
</aff><aff id="ccr32581-aff-0003">
<label><sup>3</sup></label>
<named-content content-type="organisation-division">Department of Pediatrics and Child Health</named-content>
<institution>Nihon University School of Medicine</institution>
<city>Itabashi&#x02010;ku</city>
<country country="JP">Japan</country>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break/>
Suguru Uemura, Department of Pediatrics, Kobe University Graduate School of Medicine, Kusunokicho 7&#x02010;5&#x02010;2, Chuo&#x02010;ku, Kobe 650&#x02010;0017, Japan.<break/>
Email: <email>sgr3u31@yahoo.co.jp</email><break/></corresp></author-notes><pub-date pub-type="epub"><day>17</day><month>12</month><year>2019</year></pub-date><pub-date pub-type="collection"><month>1</month><year>2020</year></pub-date><volume>8</volume><issue>1</issue><issue-id pub-id-type="doi">10.1002/ccr3.v8.1</issue-id><fpage>75</fpage><lpage>78</lpage><history><date date-type="received"><day>11</day><month>6</month><year>2019</year></date><date date-type="rev-recd"><day>22</day><month>9</month><year>2019</year></date><date date-type="accepted"><day>17</day><month>10</month><year>2019</year></date></history><permissions><!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2020 John Wiley & Sons Ltd. <copyright-statement>--><copyright-statement content-type="article-copyright">&#x000a9; 2019 The Authors. <italic>Clinical Case Reports</italic> published by John Wiley &#x00026; Sons Ltd</copyright-statement><license license-type="creativeCommonsBy"><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:CCR3-8-75.pdf"/><abstract id="ccr32581-abs-0001"><title>Abstract</title><p>The present case underscores the importance of considering the association of severe thrombocytopenia or immune thrombocytopenia with cytomegalovirus (CMV) infection because CMV&#x02010;induced thrombocytopenia occasionally requires antiviral therapy.</p></abstract><abstract abstract-type="graphical" id="ccr32581-abs-0002"><p>The present case underscores the importance of considering the association of severe thrombocytopenia or immune thrombocytopenia with cytomegalovirus (CMV) infection because CMV&#x02010;induced thrombocytopenia occasionally requires antiviral therapy.<boxed-text position="anchor" content-type="graphic" id="ccr32581-blkfxd-0001" orientation="portrait"><graphic xlink:href="CCR3-8-75-g002.jpg" position="anchor" id="nlm-graphic-1" orientation="portrait"/></boxed-text>
</p></abstract><kwd-group kwd-group-type="author-generated"><kwd id="ccr32581-kwd-0001">cytomegalovirus</kwd><kwd id="ccr32581-kwd-0002">infant</kwd><kwd id="ccr32581-kwd-0003">intravenous immunoglobulin</kwd><kwd id="ccr32581-kwd-0004">thrombocytopenia</kwd></kwd-group><counts><fig-count count="1"/><table-count count="0"/><page-count count="4"/><word-count count="2018"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>January 2020</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:5.7.5 mode:remove_FC converted:25.01.2020</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="journal" id="ccr32581-cit-1001">
<string-name>
<surname>Uemura</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Mori</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Nino</surname>
<given-names>N</given-names>
</string-name>, et al. <article-title>An infant with refractory cytomegalovirus&#x02010;induced thrombocytopenia</article-title>. <source xml:lang="en">Clin Case Rep</source>. <year>2020</year>;<volume>8</volume>:<fpage>75</fpage>&#x02013;<lpage>78</lpage>. <pub-id pub-id-type="doi">10.1002/ccr3.2581</pub-id>
</mixed-citation>
</p></notes></front><body id="ccr32581-body-0001"><sec sec-type="background" id="ccr32581-sec-0001"><label>1</label><title>BACKGROUND</title><p>Most cases of cytomegalovirus (CMV) infection are asymptomatic or self&#x02010;limited in immunocompetent patients. However, CMV infection occasionally induces severe thrombocytopenia.<xref rid="ccr32581-bib-0001" ref-type="ref">1</xref>, <xref rid="ccr32581-bib-0002" ref-type="ref">2</xref>, <xref rid="ccr32581-bib-0003" ref-type="ref">3</xref>, <xref rid="ccr32581-bib-0004" ref-type="ref">4</xref>, <xref rid="ccr32581-bib-0005" ref-type="ref">5</xref>, <xref rid="ccr32581-bib-0006" ref-type="ref">6</xref> Immune thrombocytopenia (ITP) is an autoimmune disease characterized by isolated thrombocytopenia due to the inhibition of platelet production and destruction of existing platelets.<xref rid="ccr32581-bib-0001" ref-type="ref">1</xref> Moreover, it is the most common cause of pediatric thrombocytopenia.<xref rid="ccr32581-bib-0001" ref-type="ref">1</xref> Although the etiology of ITP remains unknown in most cases, it may be triggered by viral infections such as by CMV or by other immunological and environmental agents.<xref rid="ccr32581-bib-0007" ref-type="ref">7</xref> Severe and life&#x02010;threatening hemorrhage is very rare (&#x0003c;1.0%) in such cases.<xref rid="ccr32581-bib-0008" ref-type="ref">8</xref>, <xref rid="ccr32581-bib-0009" ref-type="ref">9</xref> CMV&#x02010;related secondary ITP often occurs a few weeks after the onset of CMV infection symptoms such as fever, elevated liver enzymes, hepatosplenomegaly, and cervical lymphadenopathy, because of the occurrence of underlying immunological reaction during this period.<xref rid="ccr32581-bib-0003" ref-type="ref">3</xref>, <xref rid="ccr32581-bib-0004" ref-type="ref">4</xref> Meanwhile, CMV infects megakaryocytes directly, causing CMV infection symptoms at the time of thrombocytopenia diagnosis. This mechanism is regarded as CMV&#x02010;induced thrombocytopenia.<xref rid="ccr32581-bib-0003" ref-type="ref">3</xref>, <xref rid="ccr32581-bib-0004" ref-type="ref">4</xref>
</p><p>It is difficult to distinguish CMV&#x02010;induced thrombocytopenia from CMV&#x02010;related secondary ITP. However, early detection of CMV infection is paramount because CMV&#x02010;induced thrombocytopenia occasionally requires antiviral therapy.<xref rid="ccr32581-bib-0003" ref-type="ref">3</xref> Herein, we report a case of refractory CMV&#x02010;induced thrombocytopenia in a 38&#x02010;day&#x02010;old infant.</p></sec><sec id="ccr32581-sec-0002"><label>2</label><title>CLINICAL CASE REPORT</title><p>A 38&#x02010;day&#x02010;old boy was admitted to our hospital because of the presence of petechiae from trunk to legs and oral wet purpura. His mother was a 35&#x02010;year&#x02010;old woman (gravid 2, para 2) with no remarkable medical history. Her pregnancy course was uncomplicated, and her platelet count was also normal during pregnancy. There were no hemorrhagic episodes during the perinatal period of the boy, and he was born at full term via aspiration delivery. His weight at birth was 3304&#x000a0;g. The baby was breast&#x02010;fed and had no remarkable family history. He underwent a medical check&#x02010;up on the 31st day after birth, which revealed no particular problems. At admission, he was afebrile with blood pressure of 98/60&#x000a0;mm&#x000a0;Hg, pulse of 142/min, respiratory rate of 36/min, and O<sub>2</sub> saturation of 100% on room air. He had neither hepatomegaly nor splenomegaly. A laboratory examination showed a white blood cell count of 23&#x000a0;600/&#x000b5;L with 11.0% atypical lymphocytes, CD4&#x02010;positive cell count of 1044/&#x000b5;L, a hemoglobin level of 11.9&#x000a0;g/dL, and platelet count of 4000/&#x000b5;L. Immature platelet fraction was normal (2.9%). CD4/CD8 ratio was also normal (0.82). The size of platelet was normal. The aspartate aminotransferase and alanine aminotransferase levels were 59&#x000a0;IU/L and 55&#x000a0;IU/L, respectively. Immunoglobulin G (IgG), IgA, and IgM were 773, 21, and 50&#x000a0;mg/dL, respectively. A coagulation test was normal. His chest/abdominal CT findings were normal.</p><p>Platelet transfusion was performed after admission because ITP was not suspected due to his age. However, his platelet count was only 12&#x000a0;000/&#x000b5;L after platelet transfusion (Figure <xref rid="ccr32581-fig-0001" ref-type="fig">1</xref>). IVIG (1&#x000a0;g/kg) was subsequently administered because of the refractoriness to transfusion, which was suspected to be due to ITP. Despite IVIG administration, his platelet count decreased to 2000/&#x000b5;L. Although another platelet transfusion was performed, his platelet count increased only to 9000/&#x000b5;L. A subsequent bone marrow examination showed a nuclear cell count of 105&#x000a0;000/&#x000b5;L without morphologically abnormal cells and megakaryocyte count of 8/&#x000b5;L. After the exclusion of malignant diseases, prednisolone (PSL; 1&#x000a0;mg/kg) was administered as a second&#x02010;line therapy for ITP with another platelet transfusion. After the initiation of PSL therapy, his platelet count increased to 31&#x000a0;000/&#x000b5;L, but decreased to 18&#x000a0;000/&#x000b5;L after 2&#x000a0;days. CMV infection was diagnosed based on the presence of CMV IgM (1.64) and IgG (14.2), and the results of a CMV antigenemia assay using monoclonal antibodies C10/C11 (4 positive cells/ 150&#x000a0;000 leukocytes) at admission. IVIG (1&#x000a0;g/kg) were re&#x02010;administered, and PSL dose was increased to 2&#x000a0;mg/kg. Thereafter, his platelet count gradually normalized. Thrombocytopenia has not recurred after the discontinuation of PSL. The patient has been normal development, without recurrence, for more than 6&#x000a0;months after onset. Using quantitative PCR analysis, CMV&#x02010;DNA was detected in his urine after treatment but not in his dried umbilical cord. Based on these results, thrombocytopenia was associated with acquired CMV infection. No abnormalities were observed on brain magnetic resonance imaging. Auditory brainstem responses revealed normal waves from I to V at 90&#x000a0;dB and V wave was detected at 30dB. These clinical findings indicate that the patient was infected with CMV after birth, excluding a congenitally acquired infection.</p><fig fig-type="Figure" xml:lang="en" id="ccr32581-fig-0001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Clinical course of our patient. IVIG, intravenous immunoglobulin; PC, platelet transfusion; Plt, platelet count; PSL, prednisolone</p></caption><graphic id="nlm-graphic-3" xlink:href="CCR3-8-75-g001"/></fig></sec><sec sec-type="discussion" id="ccr32581-sec-0003"><label>3</label><title>DISCUSSION</title><p>Herein, we described a 38&#x02010;day&#x02010;old boy with CMV&#x02010;induced thrombocytopenia. Our initial diagnosis was ITP. Retrospectively, however, CMV&#x02010;induced thrombocytopenia is more suitable in the patient's diagnosis, because immune system and lymphoid activation are immature for his age and the general peak occurrence of ITP in childhood is between 2 and 5&#x000a0;years of age.<xref rid="ccr32581-bib-0010" ref-type="ref">10</xref>
</p><p>In a 38&#x02010;day&#x02010;old infant, either congenital or acquired CMV infection can occur. Thrombocytopenia often occurs in patients with congenital CMV infection.<xref rid="ccr32581-bib-0011" ref-type="ref">11</xref> In our case, quantitative PCR did not reveal CMV&#x02010;DNA in his dried umbilical cord at birth,<xref rid="ccr32581-bib-0012" ref-type="ref">12</xref> indicating acquired CMV infection. The detection of CMV&#x02010;DNA in the dried umbilical cord is useful to prove congenital CMV infection.<xref rid="ccr32581-bib-0013" ref-type="ref">13</xref> In preterm babies, acquired CMV infection can occur through breast milk because of the low level of anti&#x02010;CMV antibodies transmitted via the placenta.<xref rid="ccr32581-bib-0014" ref-type="ref">14</xref> Because the status of maternal CMV infection was not evaluated, the infection route of CMV remained to be determined in our case. CDC recommends that congenital CMV infection should be diagnosed based on the presence of CMV&#x02010;DNA in the urine, saliva, or blood, within 3&#x000a0;weeks after birth. Infection cannot be diagnosed using tests that detect antibodies to CMV.<xref rid="ccr32581-bib-0015" ref-type="ref">15</xref> Moreover, congenital CMV infection cannot be diagnosed using samples collected more than three weeks after birth because testing after this time cannot distinguish between a congenital infection and an infection acquired during or after delivery.<xref rid="ccr32581-bib-0015" ref-type="ref">15</xref> In our case, we could not access other samples within 3&#x000a0;weeks after his birth to detect congenital CMV infection and the possibility of false&#x02010;negative results of CMV in the dried umbilical cord cannot thus be ruled out. Therefore, we could not rule out congenital CMV infection completely.</p><p>Thrombocytopenia in neonates is relatively common, occurring in 1%&#x02010;5% of healthy term infants and in 20%&#x02010;50% of sick infants. Frequent etiologies include sepsis, disseminated intravascular coagulation, respiratory distress syndrome, and maternal factors, among others.<xref rid="ccr32581-bib-0016" ref-type="ref">16</xref> Thrombocytopenia due to maternal factors is caused by ITP, systemic lupus erythematosus, and drugs.<xref rid="ccr32581-bib-0016" ref-type="ref">16</xref> However, in our case, his mother showed no problems during pregnancy, did not receive any thrombocytopenia&#x02010;inducing drugs, and did not show any remarkable medical history. Her platelet count was also normal. Therefore, we judged that there was no association between thrombocytopenia and maternal causes in this case.</p><p>Neonatal alloimmune thrombocytopenia (NAIT) is the most common cause of severe thrombocytopenia in newborns.<xref rid="ccr32581-bib-0017" ref-type="ref">17</xref> Typical patients with NAIT develop petechiae within minutes of birth, followed by ecchymosis and cephalohematoma.<xref rid="ccr32581-bib-0017" ref-type="ref">17</xref> After delivery, the greatest risk of hemorrhage is in the first 96&#x000a0;hours of life. Thrombocytopenia in patients with NAIT resolves naturally within 1&#x02010;2&#x000a0;weeks after birth.<xref rid="ccr32581-bib-0017" ref-type="ref">17</xref> Because there were also no hemorrhagic episodes in his perinatal period, we judged that there was no association between thrombocytopenia and NAIT in this case, although anti&#x02010;human platelet antigen alloantibodies were not tested.</p><p>In the retrospective analysis, there were no significant differences between CMV&#x02010;induced thrombocytopenia and CMV&#x02010;related secondary ITP in terms of age, sex, and platelet count at diagnosis.<xref rid="ccr32581-bib-0003" ref-type="ref">3</xref> Interestingly, antiviral therapy was required in 8 of the 23 patients with CMV&#x02010;induced thrombocytopenia, while no patients with CMV&#x02010;related secondary ITP required antiviral therapy. Furthermore, some patients with CMV&#x02010;induced thrombocytopenia showed complicated clinical courses such as refractory or chronic courses, compared with CMV&#x02010;related secondary ITP. The data of bone marrow examination did not give new knowledge about CMV&#x02010;induced thrombocytopenia and CMV&#x02010;related secondary ITP, because a few patients underwent bone marrow examination.</p><p>In conclusion, CMV should be evaluated in suspected cases of refractory thrombocytopenia because CMV infection occasionally induces severe and refractory thrombocytopenia, requiring antiviral therapy.</p></sec><sec sec-type="COI-statement" id="ccr32581-sec-0004"><title>CONFLICTS OF INTEREST</title><p>The authors have no conflicts of interests to declare.</p></sec><sec id="ccr32581-sec-0005"><title>AUTHOR CONTRIBUTIONS</title><p>SU, TM, NN, NS, ST, SM, YT, and MK: participated in patient's evaluation and treatment. SU, TM, IM, NN, MK, and KI: reviewed and revised the manuscript. All authors read and approved the final manuscript.</p></sec></body><back><ref-list content-type="cited-references" id="ccr32581-bibl-0001"><title>REFERENCES</title><ref id="ccr32581-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="ccr32581-cit-0001">
<string-name>
<surname>DiMaggio</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Anderson</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Bussel</surname>
<given-names>JB</given-names>
</string-name>. <article-title>Cytomegalovirus can make immune thrombocytopenic purpura refractory</article-title>. <source xml:lang="en">Br J Haematol</source>. <year>2009</year>;<volume>146</volume>:<fpage>104</fpage>&#x02010;<lpage>112</lpage>.<pub-id pub-id-type="pmid">19438507</pub-id></mixed-citation></ref><ref id="ccr32581-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="ccr32581-cit-0002">
<string-name>
<surname>Shimanovsky</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Patel</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Wasser</surname>
<given-names>J</given-names>
</string-name>. <article-title>Refractory immune thrombocytopenic purpura and cytomegalovirus infection: a call for a change in the current guidelines</article-title>. <source xml:lang="en">Mediterr J Hematol Infect Dis</source>. <year>2016</year>;<volume>8</volume>:<elocation-id>e2016010</elocation-id>.<pub-id pub-id-type="pmid">26740871</pub-id></mixed-citation></ref><ref id="ccr32581-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="ccr32581-cit-0003">
<string-name>
<surname>Jin</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Choi</surname>
<given-names>EM</given-names>
</string-name>, et al. <article-title>Clinical characteristics and treatment courses for cytomegalovirus&#x02010;associated thrombocytopenia in immunocompetent children after neonatal period</article-title>. <source xml:lang="en">Blood Res</source>. <year>2018</year>;<volume>53</volume>:<fpage>110</fpage>&#x02010;<lpage>116</lpage>.<pub-id pub-id-type="pmid">29963516</pub-id></mixed-citation></ref><ref id="ccr32581-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="ccr32581-cit-0004">
<string-name>
<surname>Nishio</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Kawano</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Kawada</surname>
<given-names>JI</given-names>
</string-name>, <string-name>
<surname>Ito</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Hara</surname>
<given-names>S</given-names>
</string-name>. <article-title>A case of refractory cytomegalovirus&#x02010;related thrombocytopenia that achieved complete remission without antiviral therapy</article-title>. <source xml:lang="en">J Infect Chemother</source>. <year>2018</year>;<volume>24</volume>:<fpage>995</fpage>&#x02010;<lpage>997</lpage>.<pub-id pub-id-type="pmid">30001843</pub-id></mixed-citation></ref><ref id="ccr32581-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="ccr32581-cit-0005">
<string-name>
<surname>Sakata</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Ikegami</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Nagaya</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Shirai</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Maruyama</surname>
<given-names>S</given-names>
</string-name>. <article-title>Thrombocytopenia caused by acquired cytomegalovirus infection in children</article-title>. <source xml:lang="en">Pediatr Int</source>. <year>1999</year>;<volume>41</volume>:<fpage>113</fpage>&#x02010;<lpage>114</lpage>.<pub-id pub-id-type="pmid">10200150</pub-id></mixed-citation></ref><ref id="ccr32581-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="ccr32581-cit-0006">
<string-name>
<surname>Mizutani</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Azuma</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Komada</surname>
<given-names>Y</given-names>
</string-name>, et al. <article-title>An infantile case of cytomegalovirus induced idiopathic thrombocytopenic purpura with predominant proliferation of CD10 positive lymphoblast in bone marrow</article-title>. <source xml:lang="en">Acta Pediatr Jpn</source>. <year>1995</year>;<volume>37</volume>:<fpage>71</fpage>&#x02010;<lpage>74</lpage>.</mixed-citation></ref><ref id="ccr32581-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="ccr32581-cit-0007">
<string-name>
<surname>Provan</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Stasi</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Newland</surname>
<given-names>AC</given-names>
</string-name>, et al. <article-title>International consensus report on the investigation and management of primary immune thrombocytopenia</article-title>. <source xml:lang="en">Blood</source>. <year>2010</year>;<volume>115</volume>:<fpage>1668</fpage>&#x02010;<lpage>1686</lpage>.</mixed-citation></ref><ref id="ccr32581-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="ccr32581-cit-0008">
<string-name>
<surname>Imbach</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>K&#x000fc;hne</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>M&#x000fc;ller</surname>
<given-names>D</given-names>
</string-name>, et al. <article-title>Childhood ITP: 12 months follow&#x02010;up data from the prospective registry I of the Intercontinental Childhood ITP Study Group (ICIS)</article-title>. <source xml:lang="en">Pediatr Blood Cancer</source>. <year>2006</year>;<volume>46</volume>:<fpage>351</fpage>&#x02010;<lpage>356</lpage>.<pub-id pub-id-type="pmid">16086422</pub-id></mixed-citation></ref><ref id="ccr32581-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="ccr32581-cit-0009">
<string-name>
<surname>Butros</surname>
<given-names>LJ</given-names>
</string-name>, <string-name>
<surname>Bussel</surname>
<given-names>JB</given-names>
</string-name>. <article-title>Intracranial hemorrhage in immune thrombocytopenic purpura: a retrospective analysis</article-title>. <source xml:lang="en">J Pediatr Hematol Oncol</source>. <year>2003</year>;<volume>25</volume>:<fpage>660</fpage>&#x02010;<lpage>664</lpage>.<pub-id pub-id-type="pmid">12902925</pub-id></mixed-citation></ref><ref id="ccr32581-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="ccr32581-cit-0010">
<string-name>
<surname>K&#x000fc;hne</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Buchanan</surname>
<given-names>GR</given-names>
</string-name>, <string-name>
<surname>Zimmerman</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the Intercontinental Childhood ITP Study Group</article-title>. <source xml:lang="en">J Pediatr</source>. <year>2003</year>;<volume>143</volume>:<fpage>605</fpage>&#x02010;<lpage>608</lpage>.<pub-id pub-id-type="pmid">14615730</pub-id></mixed-citation></ref><ref id="ccr32581-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="ccr32581-cit-0011">
<string-name>
<surname>Kylat</surname>
<given-names>RI</given-names>
</string-name>, <string-name>
<surname>Kelly</surname>
<given-names>EN</given-names>
</string-name>, <string-name>
<surname>Ford&#x02010;Jones</surname>
<given-names>EL</given-names>
</string-name>. <article-title>Clinical findings and adverse outcome in neonates with symptomatic congenital cytomegalovirus (SCCMV) infection</article-title>. <source xml:lang="en">Eur J Pediatr</source>. <year>2006</year>;<volume>165</volume>:<fpage>773</fpage>&#x02010;<lpage>778</lpage>.<pub-id pub-id-type="pmid">16835757</pub-id></mixed-citation></ref><ref id="ccr32581-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="ccr32581-cit-0012">
<string-name>
<surname>Watzinger</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Suda</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Preuner</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>Real&#x02010;time quantitative PCR assays for detection and monitoring of pathogenic human viruses in immunosuppressed pediatric patients</article-title>. <source xml:lang="en">J Clin Microbiol</source>. <year>2004</year>;<volume>42</volume>:<fpage>5189</fpage>&#x02010;<lpage>5198</lpage>.<pub-id pub-id-type="pmid">15528714</pub-id></mixed-citation></ref><ref id="ccr32581-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="ccr32581-cit-0013">
<string-name>
<surname>Koyano</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Araki</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Hirano</surname>
<given-names>Y</given-names>
</string-name>, et al. <article-title>Retrospective diagnosis of congenital cytomegalovirus infection using dried umbilical cords</article-title>. <source xml:lang="en">Pediatr Infect Dis J</source>. <year>2004</year>;<volume>23</volume>:<fpage>481</fpage>&#x02010;<lpage>482</lpage>.<pub-id pub-id-type="pmid">15131484</pub-id></mixed-citation></ref><ref id="ccr32581-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="ccr32581-cit-0014">
<string-name>
<surname>Lanzieri</surname>
<given-names>TM</given-names>
</string-name>, <string-name>
<surname>Dollard</surname>
<given-names>SC</given-names>
</string-name>, <string-name>
<surname>Josephson</surname>
<given-names>CD</given-names>
</string-name>, <string-name>
<surname>Schmid</surname>
<given-names>DS</given-names>
</string-name>, <string-name>
<surname>Bialek</surname>
<given-names>SR</given-names>
</string-name>. <article-title>Breast milk&#x02010;acquired cytomegalovirus infection and disease in VLBW and premature infants</article-title>. <source xml:lang="en">Pediatrics</source>. <year>2013</year>;<volume>131</volume>:<fpage>e1937</fpage>&#x02010;<lpage>e1945</lpage>.<pub-id pub-id-type="pmid">23713111</pub-id></mixed-citation></ref><ref id="ccr32581-bib-0015"><label>15</label><mixed-citation publication-type="miscellaneous" id="ccr32581-cit-0015">
<collab collab-type="authors">Centers for Disease Control and Prevention</collab>
.<article-title>Cytomegalovirus (CMV) and congenital CMV infection</article-title>. <year>2019</year>
<ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/cmv/clinical/lab-tests.html">https://www.cdc.gov/cmv/clinical/lab-tests.html</ext-link>. Accessed November 27, 2019.</mixed-citation></ref><ref id="ccr32581-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="ccr32581-cit-0016">
<string-name>
<surname>Chakravorty</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Roberts</surname>
<given-names>I</given-names>
</string-name>. <article-title>How I manage neonatal thrombocytopenia</article-title>. <source xml:lang="en">Br J Haematol</source>. <year>2012</year>;<volume>156</volume>:<fpage>155</fpage>&#x02010;<lpage>162</lpage>.<pub-id pub-id-type="pmid">21950766</pub-id></mixed-citation></ref><ref id="ccr32581-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="ccr32581-cit-0017">
<string-name>
<surname>Bakchoul</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Bassler</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Heckmann</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>Management of infants born with severe neonatal alloimmune thrombocytopenia: the role of platelet transfusions and intravenous immunoglobulin</article-title>. <source xml:lang="en">Transfusion</source>. <year>2014</year>;<volume>54</volume>:<fpage>640</fpage>&#x02010;<lpage>645</lpage>.<pub-id pub-id-type="pmid">23869512</pub-id></mixed-citation></ref></ref-list></back></article>